BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36320800)

  • 1. Strategies in the Management of Pancreatic Ductal Adenocarcinoma Involving Aberrant Right Hepatic Artery Arising From the Superior Mesenteric Artery.
    Maharjan DK; Ghimire R; Limbu Y; Regmee S; Pahari R; Shrestha SK; Thapa PB
    Cureus; 2022 Oct; 14(10):e30781. PubMed ID: 36320800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma.
    Limbu Y; Regmee S; Ghimire R; Maharjan DK; Thapa PB
    Cureus; 2021 Dec; 13(12):e20275. PubMed ID: 34912651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aberrant right hepatic artery on survival after pancreatic resection for ductal adenocarcinoma of the pancreatic head.
    Petrova E; Mazzella E; Eichler K; Gruber-Rouh T; Schulze F; Bechstein WO; Schnitzbauer AA
    Langenbecks Arch Surg; 2024 Apr; 409(1):111. PubMed ID: 38587539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of aberrant right hepatic arteries does not affect safety and oncological radicality of pancreaticoduodenectomy-own results and a systematic review of the literature.
    Pyras C; Lukas C; Janot-Matuschek M; Herzog T; Tannapfel A; Uhl W; Belyaev O
    Hepatobiliary Surg Nutr; 2022 Feb; 11(1):25-37. PubMed ID: 35284530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.
    Delpero JR; Sauvanet A
    Front Oncol; 2020; 10():40. PubMed ID: 32117714
    [No Abstract]   [Full Text] [Related]  

  • 6. Aberrant right hepatic artery in pancreaticoduodenectomy for adenocarcinoma: impact on resectability and postoperative outcomes.
    Kim PT; Temple S; Atenafu EG; Cleary SP; Moulton CA; McGilvray ID; Gallinger S; Greig PD; Wei AC
    HPB (Oxford); 2014 Mar; 16(3):204-11. PubMed ID: 23782313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periarterial and Sub-adventitial Divestment Along with Triangle Operation and RAMPS for Pancreatic Body Cancer.
    Kumar NAN; Palod A; Usman N; Ahmed S
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38714624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does an aberrant right hepatic artery really influence the short- and long-term results of a pancreaticoduodenectomy for malignant disease? A matched case-controlled study.
    Sulpice L; Rayar M; Paquet C; Bergeat D; Merdrignac A; Cunin D; Meunier B; Boudjema K
    J Surg Res; 2013 Dec; 185(2):620-5. PubMed ID: 24011920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A replaced right hepatic artery adjacent to pancreatic carcinoma should be divided to obtain R0 resection in pancreaticoduodenectomy.
    Okada K; Kawai M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Tani M; Yamaue H
    Langenbecks Arch Surg; 2015 Jan; 400(1):57-65. PubMed ID: 25359559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
    Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
    Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surgery Justified?
    Miura Y; Ohgi K; Sugiura T; Okamura Y; Ashida R; Yamada M; Otsuka S; Yasunaga Y; Nakagawa M; Uesaka K
    Ann Surg Oncol; 2022 Aug; 29(8):4979-4988. PubMed ID: 35362841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.
    Cesaretti M; Abdel-Rehim M; Barbier L; Dokmak S; Hammel P; Sauvanet A
    J Visc Surg; 2016 Jun; 153(3):173-81. PubMed ID: 26775202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenteric approach during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Shimokawa T; Nakao A; Yamaue H
    Ann Gastroenterol Surg; 2017 Sep; 1(3):208-218. PubMed ID: 29863125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
    Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
    J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of the presence of an aberrant right hepatic artery in patients undergoing a pancreaticoduodenectomy.
    Jah A; Jamieson N; Huguet E; Praseedom R
    Surg Today; 2009; 39(8):669-74. PubMed ID: 19639433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Patient Underwent Pancreaticoduodenectomy with Reconstruction of Replaced Right Hepatic Artery].
    Marukawa D; Murakami M; Shimizu J; Koga C; Yasuyama H; Matsumura T; Takata A; Kameda C; Kawabata R; Hirota M; Noura S; Miwa H; Hasegawa J
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):166-168. PubMed ID: 29362343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the presence of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy.
    Rammohan A; Palaniappan R; Pitchaimuthu A; Rajendran K; Perumal SK; Balaraman K; Ramasamy R; Sathyanesan J; Govindan M
    World J Gastrointest Surg; 2014 Jan; 6(1):9-13. PubMed ID: 24627736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.